China
· Delayed Price · Currency is CNY Shenzhen Kangtai Biological Products Company Description
Shenzhen Kangtai Biological Products Co., Ltd. researches and develops, produces, and sells various types of human vaccines in China.
Its marketed vaccines include SARS-COV-2 vaccines, HIB conjugate vaccines, 13-valent pneumococcal conjugate vaccines, recombinant hepatitis B vaccines, 23-valent pneumococcal polysaccharide vaccines, diphtheria tetanus acellular pertussis and haemophilus influenzae type b combined vaccines, cell-free whitebait b-type haemophilus influenzae combined vaccines, and measles and rubella combined vaccines.
The company’s research and development vaccines comprise rabies vaccine for human use, inactivated poliomyelitis vaccine, and live attenuated varicella vaccine.
Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is headquartered in Shenzhen, China.
| Country | China |
| Founded | 1992 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 1,902 |
| CEO | Xiang Miao |
Contact Details
Address: 101 kangtai Group Building Shenzhen China | |
| Phone | 86 755 2698 8658 |
| Website | biokangtai.com |
Stock Details
| Ticker Symbol | 300601 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002Q33 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Hui Zhou | Chief Financial Officer |
| Xiang Miao | President and Non-Independent Director |
| Jiankai Liu | Vice President and Non-Independent Director |
| Jin Tao | Board Secretary |